Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Manuela, Imola"'
Autor:
Martina Brandolini, Silvia Zannoli, Giulia Gatti, Valentina Arfilli, Monica Cricca, Giorgio Dirani, Agnese Denicolò, Simona Semprini, Laura Grumiro, Manuela Imola, Damiano Larne, Maria Michela Marino, Martina Manera, Andrea Mancini, Francesca Taddei, Manuel Zagarrigo, Carlo Biagetti, Vittorio Sambri
Publikováno v:
Viruses, Vol 15, Iss 2, p 291 (2023)
Literature offers plenty of cases of immunocompromised patients, who develop chronic and severe SARS-CoV-2 infections. The aim of this study is to provide further insight into SARS-CoV-2 evolutionary dynamic taking into exam a subject suffering from
Externí odkaz:
https://doaj.org/article/1d1efc319af84ab9b6e1c7dfcafe6f15
Autor:
Patrizia Tosi, Manuela Imola, Anna Maria Mianulli, Simona Tomassetti, Annalia Molinari, Serena Mangianti, Marina Ratta, Anna Merli, Valentina Polli
Publikováno v:
European Medical Journal Oncology, Vol 3, Iss 1, Pp 65-69 (2015)
Renal failure (RF) occurs in approximately 20-30% of multiple myeloma (MM) patients at diagnosis and in more than 50% of patients with advanced disease. The pathogenesis of RF is related to the production of monoclonal light chains that can damage ei
Externí odkaz:
https://doaj.org/article/fd8eb3bc67144b73990fd3c8de0a053b
Autor:
Daniele Laszlo, Claudia Cellini, Federica Monaco, Martina Chiarucci, Massimo Martino, Attilio Guarini, Elisabetta Fabbri, Eliana Zuffa, Beatrice Anna Zannetti, Attilio Olivieri, Francesco Lanza, Manuela Imola, Patrizia Tosi, Francesco Saraceni
Publikováno v:
Transplantation and cellular therapy. 27(3)
The optimal stem cell (SC) mobilization strategy for patients with multiple myeloma (MM) remains a matter of debate. Possible approaches include low or high doses of cyclophosphamide (Cy), other chemotherapeutic agents, or granulocyte colony-stimulat
Autor:
Patrizia Tosi, Manuela Imola, Mianulli Anna Maria, Simona Tomassetti, Anna Merli, Annalia Molinari, Serena Mangianti, Marina Ratta, Alessandro Isidori, Giuseppe Visani
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 4, Iss 1, Pp e2012069-e2012069 (2012)
Autologous stem cell transplantation is considered the standard of care for multiple myeloma patients aged < 65 years with no relevant comorbidities. The addition of drugs acting both on bone marrow microenvironment and on neoplastic plasma cells has
Externí odkaz:
https://doaj.org/article/10e5a62c12104e1cbe912711cb09e31e
Autor:
Alberto Ravaioli, Pier Paolo Fattori, Davide Tassinari, Giorgio Ioli, Francesca Fochessati, Emiliano Tamburini, Valentina Arcangeli, Ilaria Panzini, Maximilian Papi, Giovenzio Genestreti, Domenico Iorio, Manuela Fantini, Stefano Pulini, Anna Maria Mianulli, Sergio Sartori, G. Oliverio, Vanessa Agostini, Manuela Imola, A. Polselli, Barbara Poggi, Giancarla Monticelli, Sergio Grassia
Publikováno v:
Tumori Journal. 90:54-59
Background Cisplatin-containing regimens represent the gold standard in the treatment of advanced non-small cell lung cancer, but carboplatin is often preferred for its better toxic profile when palliation is the aim of the treatment. The synergistic
Autor:
Attilio Olivieri, Alessandro Rambaldi, Roberto M. Lemoli, Alberto Bosi, Daniele Laszlo, Nicola Cascavilla, Massimo Martino, Ilaria Scortechini, Elena Guggiari, Francesco Lanza, Giuseppe Milone, Manuela Imola, Giovanni Martinelli, Annalisa Pasini, Elisabetta Todisco, Giorgina Specchia, Vincenzo Pavone
Publikováno v:
Transfusion.
Background Although the efficacy of plerixafor in peripheral blood stem cell (PBSC) mobilization has been explored in several studies, factors associated with successful plerixafor mobilization after administration of granulocyte–colony-stimulating
Autor:
Pierpaolo Fattori, Michela Ceccolini, Anna Merli, Patrizia Tosi, Anna Maria Mianulli, Manuela Imola, Monica Tani, Simona Tomassetti, Francesco Merli, Barbara Gamberi, Alfonso Zaccaria, Claudia Cellini, Paolo Savini, Anna Lia Molinari, Barbara Castagnari
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 5, Iss 1, Pp e2013037-e2013037 (2013)
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases
Salvage therapy of elderly patients with advanced, relapsed and refractory multiple myeloma (MM) is often limited by poor marrow reserve and multi-organ impairment. In particular, renal failure occurs in up to 50% of such patients, an this can potent
Autor:
Alessandro Isidori, Manuela Imola, Mianulli Anna Maria, Simona Tomassetti, Anna Merli, Marina Ratta, Patrizia Tosi, Annalia Molinari, Giuseppe Visani, Serena Mangianti
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 4, Iss 1, Pp e2012069-e2012069 (2012)
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases
Autologous stem cell transplantation is considered the standard of care for multiple myeloma patients aged < 65 years with no relevant comorbidities. The addition of drugs acting both on bone marrow microenvironment and on neoplastic plasma cells has
Autor:
Patrizia Tosi, Barbara Castagnari, Pier Paolo Fattori, Paolo Savini, Alfonso Zaccaria, Manuela Imola, Silvana Pasini, Michele Sintini, Giovanni Martinelli, Anna Merli, Michela Ceccolini, Annalia Molinari, Anna Maria Mianulli
Abstract 5123 Vertebral compression fractures occur in approximately 60% of MM patients and can cause pain, persistent disability and dismail quality of life. Appropriate therapy of MM or radiotherapy can lead to improvement of symptoms in a signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f74900b5a7ac85ee6bca75df86f90416
http://hdl.handle.net/11585/118540
http://hdl.handle.net/11585/118540
Autor:
Britt Rudnas, Emiliano Tamburini, Alberto Ravaioli, Manuela Imola, Fabrizio Drudi, Manuela Fantini, Stefania Nicoletti, Maximilian Papi, Cinzia Possenti, Wainer Zoli, Maurizio Marangolo, Ilaria Panzini, E. Pasquini, Lorenzo Gianni
Publikováno v:
Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy ISBN: 9781603274586
Lipoplatin is a liposome encapsulated form of cisplatin. Phase I studies on Lipoplatin showed an excellent toxicity profile of the compound. Therefore we performed a phase II trial in heavily pre-treated patients with advanced non–small cell lung c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b8af1f6bba1c019647a51efbf07c3ff
https://doi.org/10.1007/978-1-60327-459-3_29
https://doi.org/10.1007/978-1-60327-459-3_29